Darwin Global Management, Ltd. Bio N Tech Se Transaction History

Darwin Global Management, Ltd.

  • $1.23 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$126.25 - $231.85 $11.4 Million - $20.9 Million
-90,057 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$216.64 - $362.52 $9.29 Million - $15.5 Million
-42,875 Reduced 32.25%
90,057 $23.2 Million
Q3 2021

Nov 15, 2021
BUY
$205.93 - $447.23 $27.4 Million - $59.5 Million
132,932 New
132,932 $36.3 Million

Others Institutions Holding BNTX

# of Institutions
357
Shares Held
38.3M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.7B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Darwin Global Management, Ltd. Portfolio

Follow Darwin Global Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Darwin Global Management, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email